Margarita Chirkina

Mrs. Margarita Chirkina

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MMMariia Romanovna Mollaeva
Mariia Romanovna Mollaeva
Nikita G YabbarovNikita G Yabbarov
Nikita G Yabbarov
MSMaria Sokol
Maria Sokol
MCMargarita Chirkina
Margarita Chirkina
MMMurad Mollaev
Murad Mollaev
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
The selection of technological parameters for nanoparticle formulation represents a complicated development phase. Therefore, the statistical analysis based on Box–Behnken methodology is widely used to optimize technological processes, including poly(lactic-co-glycolic acid) nanoparticle formulation. In this study, we applied a two-level three-factor design to optimize the preparation of nanoparticles loaded with cobalt (CoTPP), manganese (MnClTPP), and nickel (NiTPP) metalloporphyrins (MeP). The resulting nanoparticles were examined by dynamic light scattering, X-ray diffraction, Fourier transform infrared spectroscopy, MTT test, and hemolytic activity assay. The optimized model of nanoparticle formulation was validated, and the obtained nanoparticles possessed a spherical shape and physicochemical characteristics enabling them to deliver MeP in cancer cells. In vitro hemolysis assay revealed high safety of the formulated MeP-loaded nanoparticles. The MeP release demonstrated a biphasic profile and release mechanism via Fick diffusion, according to release exponent values. Formulated MeP-loaded nanoparticles revealed significant antitumor activity and ability to generate reactive oxygen species. MnClTPP- and CoTPP-nanoparticles specifically accumulated in tissues, preventing wide tissue distribution caused by long-term circulation of the hydrophobic drug. Our results suggest that MnClTPP- and CoTPP-nanoparticles represent the greatest potential for utilization in in anticancer therapy due to their effectiveness and safety.

1 December 2023 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
Vodyashkin AndreyVodyashkin Andrey
Vodyashkin Andrey
ASAntonina Sergorodceva
Antonina Sergorodceva
PKParfait Kezimana
Parfait Kezimana
MMMariya Morozova
Mariya Morozova
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
ATAlexey Timofeev
Alexey Timofeev
Metal–organic frameworks (MOFs) are widely used in the biomedical industry. In this study, we developed a new method for obtaining a metal–organic structure of strontium and terephthalic acid, Sr(BDC), and an alternative activation method for removing DMF from the pores. Sr(BDC) MOFs were successfully prepared and characterized by XRD, FTIR, TGA, and SEM. The importance of the activation steps was confirmed by TGA, which showed that the Sr(BDC)(DMF) sample can contain up to a quarter of the solvent (DMF) before activation. In our study, IR spectroscopy confirmed the possibility of removing DMF by ethanol treatment from the Sr-BDC crystals. A comparative analysis of the effect of the activation method on the specific surface and pore size of Sr-BDC and its sorption properties using the model drug doxorubicin showed that due to the undeveloped surface of the Sr-(BDC)(DMF) sample, it is not possible to obtain an adsorption isotherm and determine the pore size distribution, thus showing the importance of the activation step. Cytotoxicity and apoptosis assays were carried out to study the biological activity of MOFs, and we observed relatively low toxicity in the tested concentration range after 48 h, with over 92% cell survival for Sr(BDC)(DMF) and Sr(BDC)(260 °C), with a decrease only in the highest concentration (800 mg L−1). Similar results were observed in our apoptosis assays, as they revealed low apoptotic population generation of 2.52%, 3.23%, and 2.77% for Sr(BDC)(DMF), Sr(BDC) and Sr(BDC)(260 °C), respectively. Overall, the findings indicate that ethanol-activated Sr(BDC) shows potential as a safe and effective material for drug delivery.

13 December 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
MMMariia Romanovna Mollaeva
Mariia Romanovna Mollaeva
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
VBVeronika Beganovskaya
Veronika Beganovskaya
MSMaria Sokol
Maria Sokol
MCMargarita Chirkina
Margarita Chirkina
Nikita G YabbarovNikita G Yabbarov
Nikita G Yabbarov
Pheophorbide a 17-diethylene glycol ester (XL-8), is a promising high-active derivative of known photosensitizer chlorin e6 used in photodynamic therapy. However, high lipophilicity and poor tumor accumulation limit XL-8 therapeutic application. We developed a novel XL-8 loaded with poly(D,L-lactide-co-glycolide) nanoparticles using the single emulsion-solvent evaporation method. The nanoparticles possessed high XL-8 loading content (4.6%) and encapsulation efficiency (87.7%) and a small size (182 ± 19 nm), and negative surface charge (−22.2 ± 3.8 mV) contributed to a specific intracellular accumulation. Sustained biphasic XL-8 release from nanoparticles enhanced the photosensitizer photostability upon irradiation that could potentially reduce the quantity of the drug applied. Additionally, the encapsulation of XL-8 in the polymer matrix preserved phototoxic activity of the payload. The nanoparticles displayed enhanced cellular internalization. Flow cytometry and confocal laser-scanning microscopy studies revealed rapid XL-8 loaded nanoparticles distribution throughout the cell and initiation of DNA damage, glutathione depletion, and lipid peroxidation via reactive oxygen species formation. The novel nanoformulated XL-8 simultaneously revealed a significant phototoxicity accompanied with enhanced photostability, in contrast with traditional photosensitizers, and demonstrated a great potential for further in vivo studies.

1 August 2022 in Nanomedicine
Verified
Journal Article
Closed access
MSMaria Sokol
Maria Sokol
Nikita G YabbarovNikita G Yabbarov
Nikita G Yabbarov
MMMariia Romanovna Mollaeva
Mariia Romanovna Mollaeva
MCMargarita Chirkina
Margarita Chirkina
MMMurad Mollaev
Murad Mollaev
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
Background: Serious side effects caused by paclitaxel formulation, containing toxic solubilizer Cremophor® EL, and its nonspecific accumulation greatly limit clinical paclitaxel application. Aim: T... Graphical abstract

5 January 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Polina M. TyubaevaPolina M. Tyubaeva
Polina M. Tyubaeva
IVIvetta Varyan
Ivetta Varyan
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
MMMariia Romanovna Mollaeva
Mariia Romanovna Mollaeva
Nikita G YabbarovNikita G Yabbarov
Nikita G Yabbarov
APAnatoly Anatolyevich Popov
Anatoly Anatolyevich Popov
The effect of the hemin (Hmi) on the structure and properties of nanocomposite electrospun materials based on poly-3-hydroxybutyrate (PHB) is discussed in the article. The additive significantly affected the morphology of fibers allowed to produce more elastic material and provided high antimicrobial activity. The article considers also the impact of the hemin on the biocompatibility of the nonwoven material based on PHB and the prospects for wound healing.

Verified
Journal Article
Open access
PDF file
Nikita G YabbarovNikita G Yabbarov
Nikita G Yabbarov
Elena Dmitrievna NikolskayaElena Dmitrievna Nikolskaya
Elena Dmitrievna Nikolskaya
MSMaria Sokol
Maria Sokol
MMMariia Romanovna Mollaeva
Mariia Romanovna Mollaeva
MCMargarita Chirkina
Margarita Chirkina
RPRem Petrov
Rem Petrov
The conventional targeted delivery of chemotherapeutic and diagnostic agents utilizing nanocarriers is a promising approach for cancer theranostics. Unfortunately, this approach often faces hindered tumor access that decreases the therapeutic index and limits the further clinical translation of a developing drug. Here, we demonstrated a strategy of simultaneously double-targeting the drug to two distinct cites of tumor tissue: the tumor endothelium and cell surface receptors. We used fourth-generation polyamideamine dendrimers modified with a chelated Gd and functionalized with selectin ligand and alpha-fetoprotein receptor-binding peptide. According to the proposed strategy, IELLQAR peptide promotes the conjugate recruitment to the tumor inflammatory microenvironment and enhances extravasation through the interaction of nanodevice with P- and E-selectins expressed by endothelial cells. The second target moiety—alpha-fetoprotein receptor-binding peptide—enhances drug internalization into cancer cells and the intratumoral retention of the conjugate. The final conjugate contained 18 chelated Gd ions per dendrimer, characterized with a 32 nm size and a negative surface charge of around 18 mV. In vitro contrasting properties were comparable with commercially available Gd-chelate: r1 relaxivity was 3.39 for Magnevist and 3.11 for conjugate; r2 relaxivity was 5.12 for Magnevist and 4.81 for conjugate. By utilizing this dual targeting strategy, we demonstrated the increment of intratumoral accumulation, and a remarkable enhancement of antitumor effect, resulting in high-level synergy compared to monotargeted conjugates. In summary, the proposed strategy utilizing tumor tissue double-targeting may contribute to an enhancement in drug and diagnostic accumulation in aggressive tumors.